The use of MTX is associated with significant reductions in SLE Disease Activity Index and the average dose of corticosteroids in adult patients with SLE. PubMed, Lupus, 2014 Jan 7. (Also see: Systemic Lupus Erythematosus Treatments and Methotrexate)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.